NEW YORK, Nov. 14, 2016 /PRNewswire/ -- Use this report to:- Understand market dynamics of bioprinting technologies, applications, and end-user industries.- Assess specific bioprinting-related industries, including 3-D cell culture; bioinks; bioprinting instruments; skin substitutes; and organ/tissue-on-chip.- Analyze the global market scenario for bioprinting related products by application, technology, region, and end-user industry etc.- Gain insight into leading market suppliers of bioprinting products and services, and evaluate the number of patents associated with bioprinting market/industry. Highlights- The global market for bioprinting reached $263.8 million in 2015. The market should reach $295 million in 2016 and $1.8 billion by 2021, growing at a compound annual growth rate (CAGR) of 43.9% from 2016 to 2021.- The nonclinical bioprinting applications (comprised mostly of applied research) reached $263.8 million in 2015 and should reach $295 million in 2016 and $635.2 million by 2021, growing at a CAGR of 16.6% from 2016 to 2021.- The global clinical application segment in bioprinting was stable in 2015 and 2016 and should reach nearly $1.2 billion by 2021. Introduction & ScopeINTRODUCTIONSTUDY GOALS AND OBJECTIVESBCC Research's goal for this study is to provide an in-depth analysis of the bioprinting industry, which provides enabling tools to a number of industries in the life sciences,cosmetics and clinical fields. The analysis includes bioprinting technologies, applications, industries, markets, patents and companies. BCC Research examines the markets for bioprinting products and services for the years 2015, 2016 and 2021. Emphasis is placed on the main market segments for bioprinting in the research, drug discovery and development, cosmetics, and clinical fields. Also, the main bioprinting products are discussed including instruments, reagents, printed tissues, services, and software.Bioprinting market segments that provide strong growth opportunities include industrial/professional bioprinters, bioinks, tissue kits, in vitro research kits, and regenerative medicine procedures. The report provides a comprehensive discussion of bioprinting technologies, market applications, industry structure, global markets, patent status and companies. The report is designed to aid companies in their strategic planning efforts for accessing bioprinting industry opportunities. REASONS FOR DOING THE STUDY3-D printers are beginning to revolutionize the manufacturing industry and are now increasingly used to make finished parts and goods. This industry is reshapingtraditional supply chains and is enabling localization and customization in the manufacturing sector. Bioprinting is related to 3-D printing but uses living cells as wellas scaffold and other biomaterials. Bioprinting is emerging as a key manufacturing tool for tissue engineering and regenerative medicine.Key industries are now closely following developments in bioprinting, including the drug and cosmetics industries. Their main interest is in using the technology to manufacture realistic in vitro models for toxicity and disease modeling. Beyond in vitro models, 3-D printing has enormous potential in regenerative medicine applications for tissue grafting and organ replacement. These technical and market factors are driving this market so that it is now timely to examine the bioprinting markets to assess the products and applications that will become important to the industries involved.